Global Nicotinic Acid (Vitamin B3) market cagr 13.1%

Page 1

Nicotinic Acid (Vitamin B3)

Market

Nicotinic Acid (Vitamin B3) Market Scope: Industry

Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Nicotinic Acid (Vitamin B3) Market Size and Growth

The Nicotinic Acid (Vitamin B3) market research reports indicate a steady growth in demand due to shifting consumer preferences towards health and wellness products. The market size for Nicotinic Acid is projected to reach $XX million by 2025, driven by increasing awareness about the health benefits of the vitamin.

Request Sample Report

Companies Covered (Covid 19 Impact Covered)

◍ Aarti Drugs

◍ Brother Enterprises Holding

◍ DSM

◍ Jubilant Life Science

◍ Lanbo Biotechnology

◍ Lasons

◍ Lonza

◍ Nantong Acetic Acid Chemical

◍ Red Sun Group

◍ Resonance Specialties

◍ Tianjin Zhongrui Pharmaceutical

◍ Vanetta

◍ Vertellus

The competitive landscape of the Nicotinic Acid (Vitamin B3) market includes companies like Aarti Drugs, DSM, Jubilant Life Science, Lonza, and others. These companies manufacture and supply Nicotinic Acid to various industries including pharmaceuticals, food and beverage, and cosmetics, thereby contributing to the growth of the Nicotinic Acid market.

- Aarti Drugs: Sales revenue of $300 million

- DSM: Sales revenue of $8.1 billion

- Jubilant Life Science: Sales revenue of $1.3 billion Request Sample Report

Market Segmentation

By Application

◍ Feed Additives

◍ Food & Beverage

◍ Pharmaceuticals

◍ Industrial

◍ Daily Chemicals

By Product

◍ Niacin Lowers Cholesterol

◍ Others

Request Sample Report

$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.